NICE recommends Celgene’s Revlimid combo for follicular lymphoma
February 27, 2020Sales and Marketing Cancer, Celgene, NICE, Revlimid, follicular lymphoma, pharma
NICE has chosen to recommend Celgene’s Revlimid (lenalidomide) for use on the NHS, it has emerged, alongside Genentech’s Rituxan (rituximab), …
Female participation up in 2019 US clinical trials, but minority representation down
February 27, 2020Medical Communications, Research and Development FDA, clinical trials, pharma
The FDA’s Drugs Trials Snapshots 2019 report has been released, clarifying the demographic distribution of participants who were included in …
US Judge rules that a decade of unpublished trial results must be made public
February 27, 2020Medical Communications, Research and Development FDA, US, clinical trials, pharma
A federal judge in New York’s Southern District has ruled that 10 years of unpublished clinical trial data must now …
First US coronavirus trial launched into Gilead’s remdesivir
February 26, 2020Research and Development FDA, Gilead, US, coronavirus, pharma
The first US clinical trial investigating a treatment for the COVID-19 coronavirus has been launched by the US National Institute …
Takeda acquires PvP Biologics after successful Phase 1 study of Celiac Disease treatment
February 26, 2020Research and Development Celiac, PvP, Takeda, phase 1, phase III
Takeda has acquired PvP Biologics following the conclusion of a Phase 1 study of the investigational medicine TAK-062 for the …
Global cases of coronavirus rise, as first US soldier in South Korea tests positive for the virus
February 26, 2020Research and Development
The number of global cases of COVID-19 continues to rise as several nations work to contain outbreaks, in particular South …
NICE rejects Roche’s Polivy combo in relapsed or refractory diffuse large B-cell lymphoma
February 26, 2020Manufacturing and Production, Research and Development, Sales and Marketing NHS, NICE, Polivy, Roche
It has been revealed that UK drug watchdog NICE has chosen to reject Roche’s Polivy (polatuzumab vedotin), used alongside rituximab …
New Johnson & Johnson study aiming to add stroke detection to Apple Watch
February 26, 2020Research and Development Apple, Janssen, Johnson & Johnson, apple watch, iphone, stroke
Johnson & Johnson announced that Janssen Pharmaceuticals will work in collaboration with Apple to explore apps for stroke detection. It …
Scotland’s life sciences sector on track to break $8 billion by 2025
February 25, 2020Manufacturing and Production, Sales and Marketing Scotland, UK, life sciences, pharma
A new report from the Scottish Government has revealed that the country’s life sciences sector is on track to breeze …
Austerity policies blamed as English life expectancy stalls for first time in a century
February 25, 2020Manufacturing and Production England, NHS England, UCL, austerity, life expectancy
A landmark report has shown that English life expectancy has stalled for the first time in a century, and reversed …
FDA greenlights first oral, daily, non-statin therapy for lowering LDL-Cholesterol
February 25, 2020Manufacturing and Production, Sales and Marketing Esperion, FDA, Nexletol, pharma
Esperion’s ATP Citrase Lyase (ACL) inhibitor Nexletol (bempedoic acid) has secured approval from the FDA, it has emerged. It is …
World’s second largest API company to be created by Sanofi
February 25, 2020Manufacturing and Production API, APIs, China API, Coronavirus API, India API, Sanofi
Sanofi plans to create a new company in Europe dedicated to the production and marketing of active pharmaceutical ingredients (API). …
US domestic supply of 150 drugs under threat from coronavirus outbreak
February 25, 2020Manufacturing and Production MERS, Sars, US, US Coronavirus, Wuhan Coronavirus, china coronavirus, coronavirus
Disruption to the US drug production pipeline from the coronavirus could hurt its domestic supply of 150 drugs. US senators …
2020 Veeva Unified Clinical Operations Survey
February 24, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, survey, veeva
Every year, Veeva asks clinical professionals to take part in the Veeva Unified Clinical Operations Survey to help the industry …
FDA approves first adjuvanted quadrivalent flu vaccine in over-65s
February 24, 2020Sales and Marketing FDA, flu, influenza, pharma, seqirus
The FDA has just authorised its first adjuvanted quadrivalent influenza vaccine, it has been announced. Seqirus’ Fluad Quadrivalent (influenza vaccine, adjuvanted) …
Clover Biopharmaceuticals partners up with GSK to accelerate coronavirus vaccine development
February 24, 2020Sales and Marketing China, Clover Biopharmaceuticals, GSK, coronavirus, pharma
Chinese biotech firm Clover Biopharmaceuticals has joined the race to develop interventions against the ongoing coronavirus outbreak with the announcement …
Eli Lilly’s Trulicity approved in US to reduce cardiovascular events in type 2 diabetes patients
February 24, 2020Sales and Marketing Eli Lilly, Trulicity, cardiovascular disease, pharma
Eli Lilly’s Trulicity (duraglutide) has been awarded marketing authorisation from the FDA as a therapy to reduce major adverse cardiovascular …
Lundbeck’s Vyepti secures US approval for migraine prevention
February 24, 2020Sales and Marketing FDA, Lundbeck, Vyepti, migraine, pharma
Lundbeck’s Vyepti (eptinezumab-jjmr) has secured approval from the FDA, it has emerged, for the prevention of migraine in adult patients. …
FDA approval for Baudax Bio’s non-opioid painkiller Anjeso
February 24, 2020Sales and Marketing Anjeso, FDA, opioids, pharma
Baudax Bio has revealed the FDA approval of its non-opioid painkiller Anjeso (meloxicam injection) as a therapy for the management …
Merck KGaA to flog Allergopharma business to Dermapharm
February 21, 2020Medical Communications, Sales and Marketing Allergopharma, Dermapharm, Merck KGaA, pharma
German-based drugmaker Merck KGaA has confirmed its intention to divest its allergy business Allergopharma to Dermapharm, another German manufacturer of …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
